Common Type 2 Diabetes Meds Won’t Raise Breast Cancer Risk: Study
MONDAY, March 22, 2021 (HealthDay News) — Widely used diabetes and obesity drugs don’t increase the risk of breast cancer, a new study indicates. The drugs — called glucagon like peptide-1 receptor agonists or GLP-1 RAs for short — are effective in treating type 2 diabetes and obesity and inContinue Reading










